Olink Bioscience and Immuno Diagnostic sign distributorship agreement for the Finnish market
“Immuno Diagnostic with its highly complementary product portfolio is an ideal partner for Olink to bring the Duolink product line to the Finnish market” says Peter Karlberg, Director of Sales and Marketing at Olink Bioscience.
“We see a great potential market for the PLA technology in the areas of academic and industrial research in Finland. Adding the Duolink product line to our product portfolio will help us to reach our goal to provide our customers with high quality reagents for research and diagnostics” adds Marko Laine, Sales Director and Vice President of Immuno Diagnostic.
Most read news
Other news from the department business & finance
These products might interest you
Micro-Dx™ CE IVD by Molzym
Fully automated from sample to PCR analysis
Rapid identification of bacteria and fungi without time-consuming cultivation
DNA-free Taq Polymerases and Mastermixes by Molzym
DNA-free reagents for unrivalled sensitivity in molecular biology
Purity that makes the difference
Greener Alternative Products by Merck Life Science
Sustainable laboratory products for environmentally conscious research
Over 2,500 ecological alternatives to reduce your laboratory footprint
CellGenix® Growth Factors and Cytokines by Sartorius
Recombinant growth factors without animal products
Optimised cell culture for T cells and MSCs in gene therapy
Recombumin® Elite by Sartorius
ICHQ7 cGMP-compliant albumin for biotechnological applications
Increase consistency and safety for gene therapies and vaccines
DNA/RNA Shield™ SafeCollect Collection Kits by Zymo Research
Sample collection devices for simple & safe at-home testing
Best user experience for secure self-collection
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.